BOOK | OOAS | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
High risk of opioid overdose | Low risk of opioid overdose | High risk of opioid overdose | Low risk of opioid overdose | |||||||||
Mean | SD | MV regression | Mean | SD | MV regression | Mean | SD | MV regression | Mean | SD | MV regression | |
Sex | ||||||||||||
Male | 2.1 | 2.7 | ref | 4.7 | 4.2 | ref | 11.0 | 11.5 | ref | 19.3 | 13.2 | ref |
Female | 2.1 | 2.4 | 0 (-0.2-0.2) | 5.3 | 4.1 | -0.1 (-0.2–0.3) | 10.3 | 9.6 | -0.3 (-1.7-1.2) | 19.5 | 11.8 | -0.9 (-2.4-0.4) |
Age category | ||||||||||||
< 25 years | 4.1 | 3.0 | 0.2 (-0.9-1.2) | 4.8 | 4.2 | 0.6 (-0.5-0.6) | 20.0 | 16.3 | 4.5 (-2.2-11.1) | 18.3 | 10.1 | -2.3 (-5.6-0.9) |
25–29 years | 2.2 | 2.6 | 0.2 (-0.2-0.7) | 4.4 | 4.1 | 0.5 (0.0-0.9)* | 14.4 | 13.6 | 0.1 (-2.8-3) | 21.6 | 13.2 | 0.9 (-1.7-3.4) |
30–39 years | 2.0 | 2.5 | -0.5 (-0.8–0.1)** | 5.9 | 4.1 | 0.0 (-0.3-0.4) | 10.1 | 10.4 | -2.5 (-4.4–0.6)** | 20.2 | 12.8 | -2.6(-4.6–0.6)* |
40–49 years | 2.1 | 2.8 | -0.3 (-0.6-0.0)* | 5.0 | 4.2 | 0.3 (-0.1-0.6) | 11.2 | 11.2 | -1.2 (-3.1-0.8) | 18.3 | 12.4 | -0.9 (-2.9-1.2) |
> 50 years | 2.1 | 2.5 | ref | 3.9 | 3.9 | ref | 10.3 | 11.5 | ref | 18.7 | 12.4 | ref |
DAST-10 | ||||||||||||
No-substantial level problems | 2.1 | 2.7 | ref | - | - | - | 11.4 | 11.3 | ref | - | - | - |
Severe level problems | 2.0 | 2.5 | 0 (-0.2-0.2) | - | - | - | 10.5 | 11.0 | 0.5 (-0.7-1.7) | - | - | - |
Current drug treatment | ||||||||||||
Yes | 2.0 | 2.8 | ref | - | 10.4 | 11.7 | ref | - | ||||
No | 2.1 | 2.5 | 0.6 (0.4–0.8)*** | - | 11.1 | 10.8 | 1.3 (0.1–2.4)* | - | ||||
Ever overdosed | ||||||||||||
Yes | 2.0 | 2.5 | ref | - | 11.1 | 10.9 | ref | - | ||||
No | 2.2 | 2.9 | -0.3 (-0.5-0)* | - | 10.2 | 11.7 | -0.6 (-2-0.7) | - | ||||
Ever witnessed an overdose | ||||||||||||
Yes | 2.0 | 2.6 | ref | 3.6 | 3.7 | ref | 10.9 | 11.0 | ref | 15.8 | 12.1 | ref |
No | 3.1 | 2.9 | 0.1 (-0.3-0.5) | 7.7 | 3.7 | 0.5 (0.2–0.8)** | 10.7 | 13.0 | -2.3 (-4.9-0.3) | 25.9 | 10.6 | 0.1 (-1.5-1.8) |